CSIMarket
 


Becton Dickinson And Company  (BDX)
Other Ticker:  
 
 

BDX's Capital Expenditures Growth by Quarter and Year

Becton Dickinson And's Capital Expenditures results by quarter and year




BDX Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter September - 213.00 358.00 307.00
III Quarter June - 202.00 237.00 197.00
II Quarter March 253.00 222.00 195.00 213.00
I Quarter December 246.00 173.00 167.00 178.00
FY   499.00 810.00 957.00 895.00



BDX Capital Expenditures second quarter 2021 Y/Y Growth Comment
Becton Dickinson And Company achieved in the second quarter, above Company average Capital Expenditures increase of 13.96% year on year, to $ 253.00 millions.

Looking into second quarter results within Medical Equipment & Supplies industry 32 other companies have achieved higher Capital Expenditures growth. While Becton Dickinson And Company' s Capital Expenditures growth of 13.96% ranks overall at the positon no. 789 in the second quarter.




BDX Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter September - -40.5 % 16.61 % 18.08 %
III Quarter June - -14.77 % 20.3 % 1.03 %
II Quarter March 13.96 % 13.85 % -8.45 % 33.13 %
I Quarter December 42.2 % 3.59 % -6.18 % 58.93 %
FY   - -15.36 % 6.93 % 23.11 %

Financial Statements
Becton Dickinson And's second quarter 2021 Capital Expenditures $ 253.00 millions BDX's Income Statement
Becton Dickinson And's second quarter 2020 Capital Expenditures $ 222.00 millions Quarterly BDX's Income Statement
New: More BDX's historic Capital Expenditures Growth >>


BDX Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter September - 5.45 % 51.05 % 55.84 %
III Quarter June - -9.01 % 21.54 % -7.51 %
II Quarter March 2.85 % 28.32 % 16.77 % 19.66 %
I Quarter December 15.49 % -51.68 % -45.6 % -31.54 %
FY (Year on Year)   - -15.36 % 6.93 % 23.11 %




Capital Expenditures second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #172
Overall #789

Capital Expenditures Y/Y Growth Statistics
High Average Low
19.29 % 0.03 % -41.19 %
(Dec. 31, 2009)   (Sep. 30, 2012)
Capital Expenditures second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #172
Overall #789
Capital Expenditures Y/Y Growth Statistics
High Average Low
19.29 % 0.03 % -41.19 %
(Dec. 31, 2009)   (Sep. 30, 2012)

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Becton Dickinson And's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
292.11 % 19.95 % -85.14 %
(Sep 30 2015)  


BDX's II. Quarter Q/Q Capital Expenditures Comment
Becton Dickinson And Company achieved in the II. Quarter 2021 below company average Capital Expenditures growth of 2.85% quarter on quarter, to $ 253.00 millions.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Becton Dickinson And's Capital Expenditures growth quarter on quarter, overall rank is 822.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #146
Overall #822
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #32
Healthcare Sector #146
Overall #822
Capital Expenditures Q/Q Growth Statistics
High Average Low
292.11 % 19.95 % -85.14 %
(Sep 30 2015)  


BDX's II. Quarter Q/Q Capital Expenditures Comment
Becton Dickinson And Company achieved in the II. Quarter 2021 below company average Capital Expenditures growth of 2.85% quarter on quarter, to $ 253.00 millions.

Within Medical Equipment & Supplies industry 31 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Becton Dickinson And's Capital Expenditures growth quarter on quarter, overall rank is 822.


Becton Dickinson And's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Capital Expenditures 12 Months Ending $ 914.00 $ 883.00 $ 810.00 $ 955.00 $ 990.00
Y / Y Capital Expenditures Growth (TTM) -7.68 % -8.31 % -15.36 % 5.41 % 14.32 %
Year on Year Capital Expenditures Growth Overall Ranking # 1010 # 453 # 1509 # 1209 # 1146
Seqeuential Capital Expenditures Change (TTM) 3.51 % 9.01 % -15.18 % -3.54 % 2.8 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 789 # 565 # 2092 # 1534 # 1213




Cumulative Capital Expenditures growth Comment
Becton Dickinson And showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Becton Dickinson And's annual Capital Expenditures improvement would be -7.68% year on year to $914 millions.

In the Healthcare sector 204 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 453 to 1010.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
19.29 %
0.03 %
-41.19 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 33
Healthcare Sector # 205
Overall # 1010

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
23.11 %
-0.65 %
-59.07 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 172
S&P 500 # 789
Cumulative Capital Expenditures growth Comment
Becton Dickinson And showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Becton Dickinson And's annual Capital Expenditures drop would be -7.68% year on year to $914 millions.

In the Healthcare sector 204 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 453 to 1010.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
19.29 %
0.03 %
-41.19 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 33
Healthcare Sector # 205
Overall # 1010

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
23.11 %
-0.65 %
-59.07 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 172
S&P 500 # 789




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BDX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BDX's Competitors
Capital Expenditures Growth for Becton Dickinson And's Suppliers
Capital Expenditures Growth for BDX's Customers

You may also want to know
BDX's Annual Growth Rates BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2021
Magellan Health inc 24.31%$ 24.308 millions
Adma Biologics Inc 23.92%$ 23.919 millions
Irhythm Technologies Inc 23.67%$ 23.671 millions
Surgery Partners Inc 22.88%$ 22.881 millions
Lemaitre Vascular Inc22.71%$ 22.711 millions
Incyte Corp22.46%$ 22.458 millions
Insulet Corporation21.90%$ 21.898 millions
Avantor Inc 19.84%$ 19.841 millions
Keros Therapeutics Inc 19.32%$ 19.318 millions
Cytosorbents Corporation19.23%$ 19.227 millions
Encompass Health Corporation18.32%$ 18.323 millions
Covetrus Inc 18.18%$ 18.182 millions
Protara Therapeutics Inc 17.41%$ 17.408 millions
Thermogenesis Holdings Inc 17.39%$ 17.391 millions
Teva Pharmaceutical Industries Ltd17.19%$ 17.188 millions
Dentsply Sirona Inc 17.19%$ 17.188 millions
Medpace Holdings inc 17.01%$ 17.011 millions
Amgen Inc 16.90%$ 16.901 millions
Organogenesis Holdings Inc 16.83%$ 16.828 millions
Ultragenyx Pharmaceutical Inc 16.44%$ 16.444 millions
Eli Lilly And Company16.26%$ 16.260 millions
Owens and Minor Inc 15.93%$ 15.929 millions
Establishment Labs Holdings Inc 15.70%$ 15.701 millions
Acadia Pharmaceuticals Inc 15.20%$ 15.203 millions
Merck and Co Inc 15.01%$ 15.010 millions
Chembio Diagnostics Inc 14.92%$ 14.922 millions
Bio techne Corp14.22%$ 14.221 millions
Becton Dickinson And Company13.96%$ 13.964 millions
Ptc Therapeutics inc 13.77%$ 13.771 millions
Fibrogen Inc 12.85%$ 12.854 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ARMK's Profile

Stock Price

ARMK's Financials

Business Description

Fundamentals

Charts & Quotes

ARMK's News

Suppliers

ARMK's Competitors

Customers & Markets

Economic Indicators

ARMK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071